Oxbow Advisors LLC Acquires New Holdings in Omega Healthcare Investors, Inc. $OHI

Posted by George Bondi on Jul 4th, 2026

Oxbow Advisors LLC bought a new stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI – Free Report) in the first quarter, according to its most recent Form 13F filing with the SEC. The fund bought 168,256 shares of the real estate investment trust’s stock, valued at approximately $7,373,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Royal Bank of Canada boosted its position in shares of Omega Healthcare Investors by 29.4% during the first quarter. Royal Bank of Canada now owns 144,339 shares of the real estate investment trust’s stock worth $5,496,000 after buying an additional 32,798 shares during the period. Focus Partners Wealth increased its position in Omega Healthcare Investors by 3.1% in the 1st quarter. Focus Partners Wealth now owns 19,862 shares of the real estate investment trust’s stock valued at $756,000 after acquiring an additional 597 shares during the period. Sivia Capital Partners LLC acquired a new stake in Omega Healthcare Investors in the 2nd quarter valued at approximately $257,000. Guggenheim Capital LLC increased its position in Omega Healthcare Investors by 1.0% in the 2nd quarter. Guggenheim Capital LLC now owns 29,398 shares of the real estate investment trust’s stock valued at $1,077,000 after acquiring an additional 280 shares during the period. Finally, First Trust Advisors LP raised its stake in Omega Healthcare Investors by 32.8% during the 2nd quarter. First Trust Advisors LP now owns 193,099 shares of the real estate investment trust’s stock valued at $7,077,000 after acquiring an additional 47,649 shares in the last quarter. Institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Stock Performance

OHI opened at $49.38 on Friday. The company has a market capitalization of $14.71 billion, a price-to-earnings ratio of 23.86, a price-to-earnings-growth ratio of 2.10 and a beta of 0.58. The company has a debt-to-equity ratio of 0.81, a current ratio of 5.32 and a quick ratio of 5.32. Omega Healthcare Investors, Inc. has a 1-year low of $35.70 and a 1-year high of $49.41. The business has a 50 day moving average price of $46.70 and a two-hundred day moving average price of $45.88.

Omega Healthcare Investors (NYSE:OHI – Get Free Report) last issued its quarterly earnings results on Tuesday, April 28th. The real estate investment trust reported $0.47 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.49 by ($0.02). Omega Healthcare Investors had a net margin of 51.14% and a return on equity of 11.86%. The firm had revenue of $322.95 million for the quarter, compared to the consensus estimate of $264.07 million. During the same period in the previous year, the business posted $0.75 earnings per share. The business’s revenue for the quarter was up 16.7% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2026 guidance at 3.190-3.250 EPS. Research analysts predict that Omega Healthcare Investors, Inc. will post 3.1 EPS for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, May 15th. Investors of record on Monday, May 4th were paid a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, May 4th. This represents a $2.68 annualized dividend and a yield of 5.4%. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 129.47%.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on OHI. Truist Financial reduced their price target on Omega Healthcare Investors from $48.00 to $46.00 and set a “hold” rating for the company in a research report on Tuesday, June 9th. Wells Fargo & Company lifted their price objective on shares of Omega Healthcare Investors from $47.00 to $49.00 and gave the company an “equal weight” rating in a research note on Monday, June 1st. Citigroup reaffirmed a “market perform” rating on shares of Omega Healthcare Investors in a report on Monday, June 15th. UBS Group set a $47.00 target price on shares of Omega Healthcare Investors in a research report on Thursday, June 18th. Finally, Royal Bank Of Canada raised their target price on shares of Omega Healthcare Investors from $47.00 to $48.00 and gave the company a “sector perform” rating in a research note on Monday, May 4th. Five equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $48.31.

View Our Latest Stock Report on Omega Healthcare Investors

Omega Healthcare Investors Profile

(Free Report)

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.